Partial treatment response to capmatinib in <i>MET</i>-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature
Daniel S. Lefler, Marni Brisson Tierno, Babar Bashir
Abstract
gene amplification for whom capmatinib, a tyrosine kinase inhibitor with activity against c-MET, provided a partial response after cessation of chemotherapy.
Topics & Concepts
Intrahepatic CholangiocarcinomaMedicineGemcitabineChemotherapyMalignancyTolerabilityOncologyInternal medicineImmunotherapyTargeted therapyC-MetPaclitaxelCancer researchCancerAdverse effectHepatocyte growth factorReceptorCholangiocarcinoma and Gallbladder Cancer StudiesLiver physiology and pathologyPediatric Hepatobiliary Diseases and Treatments